6.56

2.96% -0.20

Bausch Health Companies Inc (BHC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché BHC Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$6.76

Aprire:

$6.71

Volume 24 ore:

1.65M

Relative Volume:

0.51

Capitalizzazione di mercato:

$2.45B

Reddito:

$10.53B

Utile/perdita netta:

$-1.23B

Rapporto P/E:

-2.0209

EPS:

-3.246

Flusso di cassa netto:

$949.99M

1 W Prestazione:

+3.80%

1M Prestazione:

+1.86%

6M Prestazione:

+16.52%

1 anno Prestazione:

-9.02%

Intervallo 1D:

$6.52

$6.72

Intervallo di 1 settimana:

$6.135

$6.99

Portata 52W:

$4.33

$8.00

Bausch Health Companies Inc Stock (BHC) Company Profile

Nome

Bausch Health Companies Inc

Settore

Healthcare (1074)

Industria

Drug Manufacturers - Specialty & Generic (87)

Telefono

514-744-6792

Indirizzo

2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC

Dipendente

20,300

Cinguettio

Prossima data di guadagno

2026-07-29

Ultimi documenti SEC

BHC's Discussions on Twitter

Compare BHC vs TAK, TEVA, HLN, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BHC Bausch Health Companies Inc	6.56	2.55B	10.53B	-1.23B	949.99M	-3.246
TAK Takeda Pharmaceutical Co Adr	18.45	57.90B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.36	42.89B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.60	43.41B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	75.81	31.00B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	487.61	22.35B	3.17B	1.29B	1.01B	27.09

Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-09	Iniziato	Barclays	Equal Weight
2024-08-02	Downgrade	Piper Sandler	Neutral → Underweight
2024-07-10	Iniziato	Raymond James	Mkt Perform
2023-09-20	Aggiornamento	Jefferies	Hold → Buy
2023-06-16	Downgrade	TD Cowen	Outperform → Market Perform
2022-07-29	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2022-07-29	Downgrade	Truist	Buy → Hold
2022-07-28	Downgrade	JP Morgan	Overweight → Neutral
2022-06-13	Ripresa	JP Morgan	Overweight
2021-03-24	Downgrade	BofA Securities	Neutral → Underperform
2021-02-17	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2021-01-22	Downgrade	Piper Sandler	Overweight → Neutral
2020-09-17	Aggiornamento	BofA Securities	Underperform → Neutral
2020-08-24	Reiterato	H.C. Wainwright	Buy
2020-06-17	Reiterato	H.C. Wainwright	Buy
2020-04-24	Iniziato	Citigroup	Buy
2020-04-02	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-01-29	Downgrade	Wolfe Research	Outperform → Peer Perform
2020-01-22	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2019-12-12	Aggiornamento	JP Morgan	Neutral → Overweight
2019-12-02	Iniziato	Goldman	Neutral
2019-10-25	Iniziato	Cowen	Outperform
2019-09-12	Iniziato	Guggenheim	Buy
2019-08-15	Aggiornamento	TD Securities	Hold → Buy
2019-07-19	Iniziato	Wolfe Research	Outperform
2019-06-11	Ripresa	Barclays	Overweight
2019-05-13	Aggiornamento	JP Morgan	Underweight → Neutral
2019-03-20	Iniziato	SunTrust	Buy
2019-01-02	Aggiornamento	Piper Jaffray	Neutral → Overweight
2018-11-05	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2018-09-13	Aggiornamento	Piper Jaffray	Underweight → Neutral

Mostra tutto

Bausch Health Companies Inc Borsa (BHC) Ultime notizie

Aug 21, 2026

Bausch Health Cos (NYSE:BHC) Insider Aimee Lenar Sells 36,827 Shares - MarketBeat

Aug 20, 2026

Bausch Health Companies Insider Sold Shares Worth $258,894, According to a Recent SEC Filing - marketscreener.com

Aug 20, 2026

FY2026 EPS Estimate for Bausch Health Cos Raised by Analyst - MarketBeat

Aug 20, 2026

Aug 19, 2026

Why Did Bausch Health (TSX:BHC) Stock Surge 5.93% on 18 August 2026? - kalkine.ca

Aug 19, 2026

Bausch Health (NYSE: BHC) officer may sell stock with vested awards listed - Stock Titan

Aug 19, 2026

Bausch Health Stock: A Post-Earnings Rally Extends on a Raised Outlook - kalkine.ca

Aug 19, 2026

Aug 18, 2026

Bausch Health Cos (NYSE:BHC) Trading Up 5.1%Should You Buy? - MarketBeat

Aug 18, 2026

Aug 17, 2026

Is Bausch Health (TSX:BHC) Ready For Resilient Growth? - Kalkine Media

Aug 17, 2026

Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners - AOL.com

Aug 17, 2026

Aug 16, 2026

Bausch Health (BHC) Advances 2.68% as Shares Test Key Resistance at $6.84Leading Diagonal - Vinanet

Aug 16, 2026

Aug 14, 2026

Bausch Health Companies Inc.: Target Price Consensus and Analysts Recommendations | BVF | CA0717341071 - marketscreener.com

Aug 14, 2026

Bausch Health Stock Gains Momentum as Stronger Earnings, Raised Outlook and Debt Progress Lift Investor Optimism - kalkine.ca

Aug 14, 2026

Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month - AOL.com

Aug 14, 2026

Aug 13, 2026

Bausch Health Stock Faces Renewed Pressure as Investor Confidence Weakens - kalkine.ca

Aug 13, 2026

Aug 12, 2026

Bausch Health: Q2 Beat And Cheap, But Debt Overhang Remains Substantial (NYSE:BHC) - Seeking Alpha

Aug 12, 2026

BHC Stock Price Prediction 2025-2026 | Bausch Health Companies Inc Forecast - 24/7 Wall St.

Aug 12, 2026

What Is Fuelling Bausch Health (TSX:BHC) Midcap Interest? - Kalkine Media

Aug 12, 2026

Is Bausch Health (TSX:BHC) Finding Sustainable Pharma Momentum? - kalkinemedia.com

Aug 12, 2026

Bausch Health Stock Faces Renewed Pressure as -1.70% Decline Signals Cautious Investor Sentiment - kalkine.ca

Aug 12, 2026

Aug 11, 2026

Bausch Health Stock Climbs 1.49% as Pharmaceutical Portfolio Strength and Debt Reduction Efforts Boost Investor Confidence - kalkine.ca

Aug 11, 2026